173 related articles for article (PubMed ID: 31639796)
21. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study.
Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y
Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098
[TBL] [Abstract][Full Text] [Related]
22. Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.
Matrood S; Apostolidis L; Schrader J; Krug S; Lahner H; Ramaswamy A; Librizzi D; Kender Z; Kröcher A; Kreutzfeldt S; Gress TM; Rinke A
Front Endocrinol (Lausanne); 2021; 12():709256. PubMed ID: 34690926
[TBL] [Abstract][Full Text] [Related]
23. A systematic overview of radiation therapy effects in skeletal metastases.
Falkmer U; Järhult J; Wersäll P; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):620-33. PubMed ID: 14596519
[TBL] [Abstract][Full Text] [Related]
24. Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias.
Albers MB; Almquist M; Bergenfelz A; Nordenström E
Langenbecks Arch Surg; 2020 Mar; 405(2):137-143. PubMed ID: 32291468
[TBL] [Abstract][Full Text] [Related]
25. The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.
Rinaldi S; Santoni M; Leoni G; Fiordoliva I; Marcantognini G; Meletani T; Armento G; Santini D; Newsom-Davis T; Tiberi M; Morgese F; Torniai M; Bower M; Berardi R
Support Care Cancer; 2019 Apr; 27(4):1255-1261. PubMed ID: 30406916
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic metastases in patients with neuroendocrine neoplasms: A multi-centre cohort study.
Tsoli M; Daskalakis K; Wedin M; Angelousi A; Povlsen S; Srirajaskanthan R; Giovos G; Weickert MO; Kogut A; Kos-Kudla B; Oleinikov K; Grozinsky-Glasberg S; Kaltsas G
J Neuroendocrinol; 2023 Apr; 35(4):e13269. PubMed ID: 37102337
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D;
Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962
[TBL] [Abstract][Full Text] [Related]
29. Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center's experience of a heterogenous entity.
Püsküllüoğlu M; Grela-Wojewoda A; Ambicka A; Pacholczak-Madej R; Pietruszka A; Mucha-Małecka A; Rudzińska A; Ziobro M; Ryś J; Mituś JW
Front Endocrinol (Lausanne); 2024; 15():1217495. PubMed ID: 38800480
[TBL] [Abstract][Full Text] [Related]
30. Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.
Fisher MD; Pulgar S; Kulke MH; Mirakhur B; Miller PJ; Walker MS; Schwartzberg LS
J Gastrointest Cancer; 2019 Dec; 50(4):816-823. PubMed ID: 30121904
[TBL] [Abstract][Full Text] [Related]
31. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
Masui T; Ito T; Komoto I; Uemoto S;
BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
33. Tumor Macroscopic Morphology Is an Important Prognostic Factor in Predicting Chemotherapeutic Efficacy and Clinical Outcomes of Patients With Colorectal Neuroendocrine Neoplasms, One Multicenter Retrospective Cohort Study.
Wang Z; An K; Li R; Liu Q
Front Endocrinol (Lausanne); 2021; 12():801741. PubMed ID: 34987482
[TBL] [Abstract][Full Text] [Related]
34. Bone metastases in neuroendocrine tumors.
Zamborsky R; Svec A; Kokavec M; Galbavy S
Bratisl Lek Listy; 2017; 118(9):529-534. PubMed ID: 29061059
[TBL] [Abstract][Full Text] [Related]
35. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
Zheng M; Li Y; Li T; Zhang L; Zhou L
Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
[TBL] [Abstract][Full Text] [Related]
37. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
[TBL] [Abstract][Full Text] [Related]
38. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
Catena L; Bichisao E; Milione M; Valente M; Platania M; Pusceddu S; Ducceschi M; Zilembo N; Formisano B; Bajetta E
Tumori; 2011; 97(5):564-7. PubMed ID: 22158484
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K
Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]